National Audit Office: Cost of settling clinical negligence claims has more than tripled in last two decades
Now at £60 billion, the government's liability for clinical
negligence claims has increased in real terms from £14.4 billion
since 2006-07 and is the second largest liability on the government
balance sheet. Cost increases in the last ten years were largely
due to a small number of high-value claims. NHS Resolution has
taken significant steps to control costs. The National Audit Office
advises that even more can be...Request free trial
The annual cost of settling clinical negligence claims has more than tripled over the past two decades, from £1.1 billion in 2006-07 to £3.6 billion in 2024-25 due to increased claim numbers and the rising costs of settlements, according to a new report from the National Audit Office (NAO).1 2 NHS Resolution (NHSR) is responsible for handling clinical negligence claims against the NHS in England. The Department of Health and Social Care (DHSC) oversees NHSR and develops policy to manage the costs of clinical negligence cases. Between 2006-07 and 2016-17, the number of settled clinical negligence cases more than doubled, from 5,625 to 11,397. Most claims related to hospital activity, but volumes have been relatively stable since they peaked in 2016-17.3 Since 2016-17 increases in costs are due to rising amounts of compensation paid out on claims. This is primarily due to a small number of very high-value claims.4 Reasons for increased compensation include advancements in medicine and treatments, and people needing more care as they live for longer. Damages on very-high value cases (with awards of £1 million or more) accounted for 68% of all costs in 2024-25, despite only constituting 2% of claims by volume. Claimant legal costs on successful claims are paid by the NHS. These have risen far more than the legal costs incurred by the NHS, increasing from £148 million in 2006-07 to £538 million in 2024-25. In contrast, NHS legal costs rose from £76 million in 2006-07 to £159 million in 2024-25. The legal costs for low-value claims (for awards of £25,000 or less) were 3.7 times higher than the damages awarded to claimants in 2024-25. Low-value claims currently make up three quarters of all claims. Plans were made by the previous government to cap the legal costs in low-value cases, but these have not been implemented following the change of government in 2024. There is also a risk that government may be paying twice in some cases: first by settling a claim, and then again by paying for further treatment as patients could go on to use publicly funded health or social care services, despite the settlement being paid with the assumption that they will use the private sector.5 The overall number of settled claims has reduced for the majority of medical specialities reviewed by the NAO, and two specialities showed a notable reduction in costs.6 The cost of clinical negligence in England appears much higher than in many other countries, as the UK offers universal healthcare, does not cap compensation, and has a more comprehensive understanding of the true cost compared to other nations. NHS Resolution and the Government Actuary's Department estimate that the cost of clinical negligence cases will continue to increase each year, with annual payments potentially reaching £4.1 billion by 2029-30. Since the NAO last reported in 2016-17, NHS Resolution has worked hard to reduce the financial and emotional cost of clinical negligence by resolving claims faster and without litigation wherever possible.7 The NAO has recommended the following steps to help DHSC and NHSR manage future risk.
Gareth Davies, head of the NAO, said: “Despite progress in containing the number of clinical negligence claims in some specialties, the increasing cost of the small number of very high value claims is driving higher costs for taxpayers. “Reducing harm to patients is clearly the best way of containing this cost. Alongside this, DHSC should consider whether the existing approach to legal costs remains proportionate for all claims, including whether alternative methods to compensate for negligent treatment could provide better outcomes for patients, with less cost overall.”
ENDS
|